You can not sell your investments in this fund for 3 years from the purchase date. Long term capital gain tax will be applicable when you sell your investments after 3 years. Current tax rate is ...

Stephens analyst Scott Fidel lowered the firm’s price target on Centene (CNC) to $73 from $75 and keeps an Equal Weight rating on the shares. At its investor day, the company framed an embedded ...

Barclays raised the firm’s price target on Centene (CNC) to $93 from $91 and keeps an Overweight rating on the shares following the investor day. Centene’s embedded earnings supports greater ...

Analyst A.J. Rice of UBS maintained a Buy rating on Centene (CNC – Research Report), with a price target of $80.00. Pick the best stocks and maximize your portfolio: Discover top-rated stocks ...

Despite forecasts that the Trump administration will slash spending on Medicaid and the Affordable Care Act, the next four years probably won’t be that bad, Centene reassured investors on ...

ST. LOUIS, Dec. 12, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC) (“the Company”), a leading healthcare enterprise committed to helping people live healthier lives, today will host its investor ...

Appeals court held pharmacy benefits company is tax exempt State said exemption only for traditional insurance companies A Centene Corp. pharmacy benefit management service company is eligible for an ...

Centene will gain $200 million in additional Medicare Advantage Star Ratings bonus payments next year after the Centers for Medicare and Medicaid Services revised its scores, CEO Sarah London told ...

Centene forecasts 2025 total revenues between $166.5 billion and $169.5 billion, with adjusted EPS exceeding $7.25. 2025 HBR projected at 88.4%-89.0%; SG&A ratio ...

Centene said it expected its adjusted earnings and premium and service revenue to rise next year. The St. Louis health insurer Thursday said it forecasts $166.5 billion to $169.5 billion in ...